Hospital de Jerez de la Frontera; Servicio de Oncologia

Jerez de la Frontera, Cadiz 11407

0 studies enrolling now · 1 studies all time

What they study most

Early Breast Cancer

Studies at this site

• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Giredestrant Plus Palbociclib Compared With Anastrozole Plus Palbociclib for Postmenopausal Women With Estrogen Receptor-Positive and HER2-Negative Untreated Early Breast Cancer (coopERA Breast Cancer) — Completed